Chemistry:Ferric derisomaltose
From HandWiki
Short description: Medication
| Clinical data | |
|---|---|
| Trade names | Monoferric, Monofer |
| AHFS/Drugs.com | Monograph |
| License data | |
| Routes of administration | Intravenous (IV) |
| ATC code |
|
| Legal status | |
| Legal status | |
| Identifiers | |
| |
| CAS Number | |
| PubChem CID | |
| DrugBank | |
| UNII | |
| KEGG | |
| Chemical and physical data | |
| Formula | C18H34FeO16+3 |
| Molar mass | 562.299 g·mol−1 |
| 3D model (JSmol) | |
| |
| |
Ferric derisomaltose (FDI), sold under the brand name Monoferric among others, is a medication for the treatment of iron deficiency anemia (IDA) in adults who have intolerance to oral iron or have had unsatisfactory response to oral iron or who have non-hemodialysis dependent chronic kidney disease (NDD-CKD).[3] It was approved for use in the United States in January 2020.[3][4][5] It is given intravenously.[3]
References
- ↑ "Monofer iron (as ferric derisomaltose) 1000 mg/10 mL solution for injection vial (290834)". 26 May 2022. https://www.tga.gov.au/resources/artg/290834.
- ↑ "Search Page - Drug and Health Product Register". 23 October 2014. https://hpr-rps.hres.ca/reg-content/regulatory-decision-summary-detail.php?lang=en&linkID=RDS00389.
- ↑ 3.0 3.1 3.2 3.3 "Monoferric- ferric derisomaltose solution". 24 January 2020. https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=55859d2d-0456-4fa9-b41f-f535accc97db.
- ↑ "Monoferric approval letter". U.S. Food and Drug Administration (FDA). 16 January 2020. https://www.accessdata.fda.gov/drugsatfda_docs/appletter/2020/208171Orig1s000ltr.pdf.
This article incorporates text from this source, which is in the public domain.
- ↑ "Drug Approval Package: Monoferric Injection". 7 May 2020. https://www.accessdata.fda.gov/drugsatfda_docs/nda/2020/208171Orig1s000TOC.cfm.
External links
- "Ferric derisomaltose". Drug Information Portal. U.S. National Library of Medicine. https://druginfo.nlm.nih.gov/drugportal/name/ferric%20derisomaltose.
 |  |
